TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183,909 | -7.6% | 65,448 | 0.0% | 0.00% | – |
| Q2 2023 | $198,962 | -70.2% | 65,448 | -81.5% | 0.00% | – |
| Q1 2023 | $666,891 | -2.9% | 354,729 | -47.3% | 0.00% | – |
| Q4 2022 | $686,750 | -21.2% | 673,284 | +103.3% | 0.00% | – |
| Q3 2022 | $871,000 | -41.3% | 331,131 | +0.7% | 0.00% | – |
| Q2 2022 | $1,483,000 | -42.4% | 328,795 | +25.8% | 0.00% | – |
| Q1 2022 | $2,573,000 | -9.5% | 261,465 | +40.6% | 0.00% | – |
| Q4 2021 | $2,844,000 | +62.5% | 186,002 | +44.1% | 0.00% | – |
| Q3 2021 | $1,750,000 | +25.4% | 129,077 | +35.9% | 0.00% | – |
| Q2 2021 | $1,395,000 | – | 94,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |